Close

Support Global Voices

To stay independent, free, and sustainable, our community needs the help of friends and readers like you.

Donate now »

See all those languages up there? We translate Global Voices stories to make the world's citizen media available to everyone.

Learn more about Lingua Translation  »

An Amazon Tribe's 500-Page Traditional-Medicine Encyclopaedia

The Amazon Rainforest supports millions of plants that could be vital ingredients in still-undiscovered medications. For that reason, many pharmaceutical companies and even the US government are currently funding projects to study the indigenous plant knowledge of native shamans and healers in the area, and develop new drugs.

The Matsés people, who live in Peru and Brazil, have created a health encyclopedia more than 500 pages long cataloging their traditional medicinal practices, preserving ancestral knowledge for younger generations. The majority of the shamans are old and without apprentices. So when they die a vast knowledge also disappears.

But, in order to avoid bio-piracy, this information remains with the Matsés people; it is only accessible in the native tongue and is only distributed within the tribe’s villages. Protective measures also include: “no scientific names are used to identify local plant species, and no plants will be pictured in detail, so as not to be identifiable to outsiders.”

“The [Matsés Traditional Medicine Encyclopedia] marks the first time shamans of an Amazonian tribe have created a full and complete transcription of their medicinal knowledge written in their own language and words,” Christopher Herndon, president and co-founder of Acaté, told Mongabay in an interview.

According to Pachamama Alliance, a global community focused on creating a sustainable future, the health and wellbeing of the Western world, often comes at a high price for indigenous peoples. As pharmaceutical companies have realized that their research generates better outcomes if they co-operate with indigenous people and tap into their wisdom, rainforest tribes are at risk of losing control over their resources.

Once the pharmaceutical companies have developed the drug, they file patents claiming exclusive rights to the medical use of the plant – hence limiting or even denying access to the plants that indigenous peoples have relied upon for centuries.

That's why in 2010, the tenth Conference of Parties (COP) to the Convention on Biological Diversity adopted the Nagoya Protocol on Access and Benefit-Sharing. It specifically addresses the issue of bioprospecting and the rights of indigenous peoples to access to forest resources, intellectual property, and adequate compensation.

Acaté, a San-Francisco-based non-profit, assisted the five shamans who compiled the encyclopaedia. In the encyclopaedia, each entry is categorized by a disease name and features explanations of how to recognise the disease according to symptoms, understand its root causes and know how to prepare medicine from specific plants to use as treatment. The entries also make readers aware of alternative therapeutic options.

The idea behind the project is to make the tribes less dependent on conventional doctors and western drugs, while maintaining their self-sufficiency.

4 comments

  • […] by Global Voices Latin America · comments (0) Donate · Share this: twitter facebook reddit […]

  • jimbojr

    Marinol, anyone?/s

  • […] An Amazon Tribe's 500-Page Traditional-Medicine Encyclopaedia “The [Matsés Traditional Medicine Encyclopedia] marks the first time shamans of an Amazonian tribe have created a full and complete transcription of their medicinal knowledge written in their own language and words,” Christopher Herndon, president and … Read more on Global Voices Online […]

  • Mele

    Indeed the indigenous people have every reason to be very cautious. I still recall a surreal sounding battle case where US companies tried to patent BASMATI rice from INDIA – and they even got through with it. On most fascinating grounds – I quote: “…the Indian government said it saw no reason for further dispute. The new patent is limited to a few variants of the rice and will not hamper export of its own basmati product, the government concluded.” Here is the info: https://tinyurl.com/qh6phwe

Join the conversation

Authors, please log in »

Guidelines

  • All comments are reviewed by a moderator. Do not submit your comment more than once or it may be identified as spam.
  • Please treat others with respect. Comments containing hate speech, obscenity, and personal attacks will not be approved.

Receive great stories from around the world directly in your inbox.

Sign up to receive the best of Global Voices
* = required field
Email Frequency



No thanks, show me the site